These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8319607)

  • 21. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
    Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD
    Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
    Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW
    Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.
    Yu MW; Chiang YC; Lien JP; Chen CJ
    Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus.
    Wild CP; Jansen LA; Cova L; Montesano R
    Environ Health Perspect; 1993 Mar; 99():115-22. PubMed ID: 8391433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography.
    Groopman JD; Donahue PR; Zhu JQ; Chen JS; Wogan GN
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6492-6. PubMed ID: 3931076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
    Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of aflatoxin B(1) adduct biomarkers by oltipraz in the tree shrew (Tupaia belangeri chinensis).
    Li Y; Su J; Qin L; Egner PA; Wang J; Groopman JD; Kensler TW; Roebuck BD
    Cancer Lett; 2000 Jun; 154(1):79-83. PubMed ID: 10799742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
    Blair IA; Oe T; Kambouris S; Chaudhary AK
    Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials.
    Kensler TW; Groopman JD
    J Cell Biochem Suppl; 1996; 25():85-91. PubMed ID: 9027603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does aflatoxin exposure in the United Kingdom constitute a cancer risk?
    Harrison JC; Carvajal M; Garner RC
    Environ Health Perspect; 1993 Mar; 99():99-105. PubMed ID: 8319666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration of the aflatoxin cyclopentenone ring to a delta-lactone reduces intercalation with DNA and decreases formation of guanine N7 adducts by aflatoxin epoxides.
    Raney KD; Gopalakrishnan S; Byrd S; Stone MP; Harris TM
    Chem Res Toxicol; 1990; 3(3):254-61. PubMed ID: 2131838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
    Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
    Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid chromatography electrospray-mass spectrometry of urinary aflatoxin biomarkers: characterization and application to dosimetry and chemoprevention in rats.
    Walton M; Egner P; Scholl PF; Walker J; Kensler TW; Groopman JD
    Chem Res Toxicol; 2001 Jul; 14(7):919-26. PubMed ID: 11453740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct synthesis of aflatoxin B1-N7 guanine adduct: a reference standard for biological monitoring of dietary aflatoxin exposure in molecular epidemiological studies.
    Vidyasagar T; Sujatha N; Sashidhar RB
    Food Addit Contam; 1997 Jul; 14(5):457-67. PubMed ID: 9328530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
    Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of aflatoxin B1-DNA adduct in rat liver by enzyme immunoassay.
    Vidyasagar T; Sujatha N; Sashidhar RB
    Analyst; 1997 Jun; 122(6):609-13. PubMed ID: 9282405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China.
    El-Nezami HS; Polychronaki NN; Ma J; Zhu H; Ling W; Salminen EK; Juvonen RO; Salminen SJ; Poussa T; Mykkänen HM
    Am J Clin Nutr; 2006 May; 83(5):1199-203. PubMed ID: 16685066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA adducts as exposure biomarkers and indicators of cancer risk.
    Poirier MC
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):907-12. PubMed ID: 9255579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro reactions of aflatoxin B1-adducted DNA.
    Groopman JD; Croy RG; Wogan GN
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5445-9. PubMed ID: 6795633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
    Bolton MG; Muñoz A; Jacobson LP; Groopman JD; Maxuitenko YY; Roebuck BD; Kensler TW
    Cancer Res; 1993 Aug; 53(15):3499-504. PubMed ID: 8339253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.